CanSinoBIO Announces Approval for its MCV4 Product Menhycia™ in China – PR Newswire
PRNewswire/ — CanSino Biologics Inc. (“CanSinoBIO”) (SSE: 688185, HKEX: 06185) announced that the National Medical Products Administration of … Read source
Click to rate this post!